We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 10,000 results
  1. A Homozygous PPP1R21 Splice Variant Associated with Severe Developmental Delay, Absence of Speech, and Muscle Weakness Leads to Activated Proteasome Function

    PPP1R21 acts as a co-factor for protein phosphatase 1 (PP1), an important serine/threonine phosphatase known to be essential for cell division,...

    Andreas Hentschel, Nancy Meyer, ... Andreas Roos in Molecular Neurobiology
    Article Open access 24 January 2023
  2. Splice Variants of G Protein-Coupled Receptors Expressed in Cancers: Effective Targeting with Monoclonal Antibodies and Antibody-Like Scaffolds As Ligands Irrespective of the Pharmacological Status of Isoforms

    G protein-coupled receptors (GPCRs) form a superfamily of approximately 800–1000 receptors, including cell surface receptors that are internalized...
    P. J. Wookey, P. Gupta, ... C. J. Hutchings in Handbook of Cancer and Immunology
    Living reference work entry 2022
  3. TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation

    Background

    TREM2 is a transmembrane receptor expressed by myeloid cells and acts to regulate their immune response. TREM2 governs the response of...

    Miguel Moutinho, Israel Coronel, ... Gary E. Landreth in Genome Medicine
    Article Open access 20 February 2023
  4. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1

    Background

    Intensive evidence has highlighted the effect of aberrant alternative splicing (AS) events on cancer progression when triggered by...

    Jun-**an Du, Yi-Hong Luo, ... Wei Zhu in Journal of Experimental & Clinical Cancer Research
    Article Open access 15 May 2021
  5. SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis

    Background

    Aberrant alternative splicing (AS) is a pervasive event during colorectal cancer (CRC) development. SF3B3 is a splicing factor component of...

    Tong Xu, **chuan Li, ... Youcai Zhang in Journal of Experimental & Clinical Cancer Research
    Article Open access 26 April 2024
  6. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis

    Background

    Dysregulation of alternative splicing (AS) triggers many tumours, understanding the roles of splicing events during tumorigenesis would...

    Sha Song, Weimin Zhang, ... Wenzhuo Zhuang in British Journal of Cancer
    Article 02 January 2023
  7. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer

    Background

    Alternative splicing complexity plays a vital role in carcinogenesis and cancer progression. Improved understanding of novel splicing...

    Qiang Sun, Ye Han, ... Dong Dong in Genome Medicine
    Article Open access 21 September 2023
  8. Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancer

    Background

    Alternative splicing (AS) plays a crucial role in transcriptomic diversity and is a hallmark of cancer that profoundly influences the...

    Zhuofan Mou, Jack Spencer, ... Lorna W. Harries in Human Genomics
    Article Open access 03 November 2023
  9. A Novel AICDA Splice-Site Mutation in Two Siblings with HIGM2 Permits Somatic Hypermutation but Abrogates Mutational Targeting

    Hyper-IgM syndrome type 2 (HIGM2) is a B cell intrinsic primary immunodeficiency caused by mutations in AICDA encoding activation-induced cytidine...

    Johannes Dirks, Gabriele Haase, ... Henner Morbach in Journal of Clinical Immunology
    Article Open access 05 March 2022
  10. Characterization of alternative splicing events and prognostic signatures in gastric cancer

    Background

    Accumulating evidences indicate that the specific alternative splicing (AS) events are linked to the occurrence and prognosis of gastric...

    Nan Zhu, Yupeng Zhao, ... Beiqin Yu in Cancer Cell International
    Article Open access 11 May 2024
  11. Novel Isoforms of Adhesion G Protein-Coupled Receptor B1 (ADGRB1/BAI1) Generated from an Alternative Promoter in Intron 17

    Brain-specific angiogenesis inhibitor 1 (BAI1) belongs to the adhesion G-protein-coupled receptors, which exhibit large multi-domain extracellular N...

    Rashed Rezwan Parag, Takahiro Yamamoto, ... Erwin G. Van Meir in Molecular Neurobiology
    Article Open access 28 June 2024
  12. Genome-wide identification and functional analysis of dysregulated alternative splicing profiles in sepsis

    Background

    An increasing body of evidence now shows that the long-term mortality of patients with sepsis are associated with various sepsis-related...

    Dilixiati Tuerdimaimaiti, Buzukela Abuduaini, ... Ajiguli Kulaxi in Journal of Inflammation
    Article Open access 25 September 2023
  13. Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing

    Background

    Circular RNAs (circRNAs) contribute to multiple biological functions and are also involved in pathological conditions such as cancer....

    Zhifei Ma, Hao Chen, ... Rong Yin in Journal of Experimental & Clinical Cancer Research
    Article Open access 17 July 2023
  14. Genome-wide analysis revealed the dysregulation of RNA binding protein-correlated alternative splicing events in myocardial ischemia reperfusion injury

    Background

    Myocardial ischemia reperfusion injury (MIRI), the tissue damage which is caused by the returning of blood supply to tissue after a period...

    Ning Ma, Hao Xu, ... **gyun Bai in BMC Medical Genomics
    Article Open access 19 October 2023
  15. LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing

    Objective

    Gastric cancer (GC) is one of the most malignant tumors worldwide. Thus, it is necessary to explore the underlying mechanisms of GC...

    Huan Deng, **gwang Gao, ... Bo Wei in Cellular Oncology
    Article 24 June 2023
  16. Methods for Characterization of Alternative RNA Splicing

    Quantification of alternative splicing to detect the abundance of differentially spliced isoforms of a gene in total RNA can be accomplished via...
    Samuel E. Harvey, **gyi Lyu, Chonghui Cheng in Long Non-Coding RNAs
    Protocol 2021
  17. Breast metastatic tumors in lung can be substituted by lung-derived malignant cells transformed by alternative splicing H19 lncRNA

    Metastasis accounts for most cancer-associated deaths; yet, this complex process remains poorly understood, particularly the relationship between...

    ** Biao Xu, Jun Cao, ... Wu Zhou in Breast Cancer Research
    Article Open access 30 May 2023
  18. CASA: a comprehensive database resource for the COVID-19 Alternative Splicing Atlas

    Background

    As a key process in transcriptional regulatory mechanisms, alternative splicing (AS) plays a crucial role in maintaining the diversity of...

    Yaxin Chen, Gang Wang, ... Sanqi An in Journal of Translational Medicine
    Article Open access 20 October 2022
  19. cFLIPS regulates alternative NLRP3 inflammasome activation in human monocytes

    The innate immune responses, including inflammasome activation, are paramount for host defense against pathogen infection. In contrast to canonical...

    Yuhui Gao, Shi Yu, ... Guangxun Meng in Cellular & Molecular Immunology
    Article 17 August 2023
  20. In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors

    Splicing changes are common in cancer and are associated with dysregulated splicing factors. Here, we analyzed RNA-seq data from 323 newly diagnosed...

    Anil Aktas Samur, Mariateresa Fulciniti, ... Nikhil C. Munshi in Blood Cancer Journal
    Article Open access 20 December 2022
Did you find what you were looking for? Share feedback.